Literature DB >> 23966171

SUMOylation of p53 mediates interferon activities.

Laura Marcos-Villar1, José V Pérez-Girón, Jéssica M Vilas, Atenea Soto, Carlos F de la Cruz-Hererra, Valerie Lang, Manuel Collado, Anxo Vidal, Manuel S Rodríguez, César Muñoz-Fontela, Carmen Rivas.   

Abstract

There is growing evidence that many host proteins involved in innate and intrinsic immunity are regulated by SUMOylation, and that SUMO contributes to the regulatory process that governs the initiation of the type I interferon (IFN) response. The tumor suppressor p53 is a modulator of the IFN response that plays a role in virus-induced apoptosis and in IFN-induced senescence. Here we demonstrate that IFN treatment increases the levels of SUMOylated p53 and induces cellular senescence through a process that is partially dependent upon SUMOylation of p53. Similarly, we show that vesicular stomatitis virus (VSV) infection induces p53 SUMOylation, and that this modification favors the control of VSV replication. Thus, our study provides evidence that IFN signaling induces p53 SUMOylation, which results in the activation of a cellular senescence program and contributes to the antiviral functions of interferon.

Entities:  

Keywords:  SUMO; antiviral activity; interferon; p53; senescence

Mesh:

Substances:

Year:  2013        PMID: 23966171      PMCID: PMC3899194          DOI: 10.4161/cc.25868

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  38 in total

1.  DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.

Authors:  Olga Moiseeva; Frédérick A Mallette; Utpal K Mukhopadhyay; Adrian Moores; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

2.  Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.

Authors:  Toru Kubota; Mayumi Matsuoka; Tsung-Hsien Chang; Prafullakumar Tailor; Tsuguo Sasaki; Masato Tashiro; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

3.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

4.  Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.

Authors:  Tianwei Li; Rasa Santockyte; Rong-Fong Shen; Ephrem Tekle; Guanghui Wang; David C H Yang; P Boon Chock
Journal:  J Biol Chem       Date:  2006-09-29       Impact factor: 5.157

5.  Regulation of two E2F-related genes in presenescent and senescent human fibroblasts.

Authors:  G P Dimri; E Hara; J Campisi
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

6.  Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.

Authors:  Christy Hebner; Melanie Beglin; Laimonis A Laimins
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

7.  Resistance to viral infection of super p53 mice.

Authors:  Cesar Munoz-Fontela; Maria Angel Garcia; Isabel Garcia-Cao; Manuel Collado; Javier Arroyo; Mariano Esteban; Manuel Serrano; Carmen Rivas
Journal:  Oncogene       Date:  2005-04-21       Impact factor: 9.867

8.  Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics.

Authors:  Alfred C O Vertegaal; Jens S Andersen; Stephen C Ogg; Ronald T Hay; Matthias Mann; Angus I Lamond
Journal:  Mol Cell Proteomics       Date:  2006-09-25       Impact factor: 5.911

9.  The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.

Authors:  Oliver Bischof; Klaus Schwamborn; Nadine Martin; Andreas Werner; Claudio Sustmann; Rudolf Grosschedl; Anne Dejean
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

10.  Transcriptional role of p53 in interferon-mediated antiviral immunity.

Authors:  César Muñoz-Fontela; Salvador Macip; Luis Martínez-Sobrido; Lauren Brown; Joseph Ashour; Adolfo García-Sastre; Sam W Lee; Stuart A Aaronson
Journal:  J Exp Med       Date:  2008-07-28       Impact factor: 14.307

View more
  11 in total

Review 1.  PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Nucleus       Date:  2014       Impact factor: 4.197

2.  Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.

Authors:  Mohamed Ali Maroui; Ghizlane Maarifi; Francis P McManus; Frédéric Lamoliatte; Pierre Thibault; Mounira K Chelbi-Alix
Journal:  Mol Cell Proteomics       Date:  2018-03-13       Impact factor: 5.911

3.  KSHV latent protein LANA2 inhibits sumo2 modification of p53.

Authors:  Marcos-Villar Laura; Carlos F de la Cruz-Herrera; Alba Ferreirós; Maite Baz-Martínez; Valerie Lang; Anxo Vidal; Cesar Muñoz-Fontela; Manuel S Rodríguez; Manuel Collado; Carmen Rivas
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.

Authors:  Lisa Ivanschitz; Yuki Takahashi; Florence Jollivet; Olivier Ayrault; Morgane Le Bras; Hugues de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

5.  Activation of the double-stranded RNA-dependent protein kinase PKR by small ubiquitin-like modifier (SUMO).

Authors:  Carlos F de la Cruz-Herrera; Michela Campagna; Maria A García; Laura Marcos-Villar; Valerie Lang; Maite Baz-Martínez; Sylvia Gutiérrez; Anxo Vidal; Manuel S Rodríguez; Mariano Esteban; Carmen Rivas
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

6.  HSV-1 ICP0: An E3 Ubiquitin Ligase That Counteracts Host Intrinsic and Innate Immunity.

Authors:  Mirna Perusina Lanfranca; Heba H Mostafa; David J Davido
Journal:  Cells       Date:  2014-05-20       Impact factor: 6.600

7.  Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.

Authors:  Francis P McManus; Véronique Bourdeau; Mariana Acevedo; Stéphane Lopes-Paciencia; Lian Mignacca; Frédéric Lamoliatte; John W Rojas Pino; Gerardo Ferbeyre; Pierre Thibault
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

Review 8.  Rhabdoviruses, Antiviral Defense, and SUMO Pathway.

Authors:  Faten El Asmi; Carlos Eduardo Brantis-de-Carvalho; Danielle Blondel; Mounira K Chelbi-Alix
Journal:  Viruses       Date:  2018-12-03       Impact factor: 5.048

Review 9.  Metabolic Control by DNA Tumor Virus-Encoded Proteins.

Authors:  Martin A Prusinkiewicz; Joe S Mymryk
Journal:  Pathogens       Date:  2021-05-06

10.  Experimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.

Authors:  Raquel Garijo; Pablo Hernández-Alonso; Carmen Rivas; Jean-Simon Diallo; Rafael Sanjuán
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.